Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real‐life data from a single center

2021 ◽  
Author(s):  
Leyla Huseynova Terzi ◽  
Neslihan Akdogan ◽  
Sibel Dogan Gunaydin ◽  
Nilgun Atakan
Keyword(s):  
Intravenous Immunoglobulin ◽  
Real Life ◽  
Single Center ◽  
Life Data ◽  
Real Life Data ◽  
Autoimmune Bullous Diseases ◽  
Bullous Diseases

Effects of Salazopyrin Used in Axial Spondyloarthritis on COVID-19 Outcomes: Real-Life Data from a Single Center

2021 ◽  
Author(s):  
Berkan Armağan ◽  
Ebru Atalar ◽  
Serdar Can Güven ◽  
Bahar Özdemir ◽  
Hatice Ecem Konak ◽  
...  
Keyword(s):  
Axial Spondyloarthritis ◽  
Real Life ◽  
Single Center ◽  
Life Data ◽  
Real Life Data

scholarly journals Real Life Data for Glecaprevir/Pibrentasvir: A Single-Center Study

2021 ◽  
Vol 2 (1) ◽  
pp. 14-18
Author(s):  
Fatma Çölkesen ◽  
Arzu Tarakçı ◽  
Fatma Kaçar ◽  
Esma Eroğlu ◽  
Şule Özdemir Armağan
Keyword(s):  
Real Life ◽  
Single Center ◽  
Life Data ◽  
Real Life Data ◽  
Single Center Study ◽  
Center Study

scholarly journals Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data

2021 ◽  
Vol 12 ◽  
Author(s):  
Nevena Skroza ◽  
Ersilia Tolino ◽  
Veronica Balduzzi ◽  
Nicoletta Bernardini ◽  
Alessandra Mambrin ◽  
...  
Keyword(s):  
Dose Adjustment ◽  
Systemic Treatment ◽  
Real Life ◽  
Efficacy And Safety ◽  
Single Center ◽  
Severe Acne ◽  
Life Data ◽  
Real Life Data ◽  
Single Center Study ◽  
Center Study

This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.

scholarly journals Accuracy of Imaging Modalities in Choledocholithiasis: A Real-Life Data

2018 ◽  
Vol 103 (3-4) ◽  
pp. 177-183
Author(s):  
Suleyman Orman ◽  
Ebubekir Senates ◽  
Celal Ulasoglu ◽  
Ilyas Tuncer
Keyword(s):  
Retrospective Study ◽  
Real Life ◽  
Reference Method ◽  
Magnetic Resonance Cholangiopancreatography ◽  
Liver Function Tests ◽  
Imaging Modalities ◽  
Single Center ◽  
Endoscopic Retrograde ◽  
Life Data ◽  
Real Life Data

In this retrospective study of real-life data, we aimed to determine the diagnostic accuracy in patients with choledocholithiasis of some current imaging modalities, including ultrasonography (US), computerized tomography (CT), magnetic resonance cholangiopancreatography (MRCP), and endoscopic retrograde cholangiopancreatography (ERCP). This study utilized a database of imaging records from 86 consecutive patients with ERCP-proven choledocholithiasis in a single-center outpatient clinic. Features of the stones found, namely number, size, localization, choledochal dilation and cholestasis, were determined using various imaging modalities and liver function tests (LFTs). Our study focused on a total of 86 patients (43 female; 43 male) who underwent the ERCP procedure. Hepatobiliary ultrasound was performed in 71 (82.6%); MRCP in 59 (68.6%); and CT in 13 (15.1%) patients. All 86 patients had choledocholithiasis: 59 (68.6%) with multiple stones and 21 (24.4%) with stones over 10 mm in diameter. Sensitivity for the presence of choledocholithiasis was 40.8% for US, 76.9% for CT, and 86.4% for MRCP, where ERCP was taken as the reference method. Even though US, CT, and MRCP are widely used as noninvasive imaging modalities for CL, in our real-life data their sensitivity for choledocholithiasis was lower than expected. MRCP is preferred when a nontherapeutic but only diagnostic evaluation is aimed for; however, while highly competent in establishing the level of choledochal dilation, it had a low yield in differentiating the localization, size, and number of the stone(s).

scholarly journals Real life data of secukinumab in ankylosing spondylitis and psoriatic arthritis: Analysis of 44 patients in a single center

2021 ◽  
Vol 13 (3) ◽  
pp. 116-120
Author(s):  
Murat Bektaş ◽  
Çiğdem Çetin ◽  
Çağrı Burak Uğurlu ◽  
Fatih Kemik ◽  
Ahmet Can Çiftçi ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Real Life ◽  
Single Center ◽  
Life Data ◽  
Real Life Data
Sign in / Sign up

Export Citation Format

Share Document